Page 3 - Virtual Research News Today

~ Event to be Webcast Live on uniQure’s Corporate Website at 8:30 a.m. EST ~ LEXINGTON, Ma. and AMSTERDAM, Nov. 17, 2022 (GLOBE NEWSWIRE) -- uniQure...

2022 Ready, Set, Go! handbook; leadership program graduates 24 more leaders; Nevada County awards outdoor visitor safety fund grants; more.

/PRNewswire/ -- Zoe Immersive, an award-winning metaverse software company with a mission to democratize content creation, and the West Allis-West Milwaukee...

The rare condition brought one Oregon family to Michigan, where a new international collaborative is improving outcomes and inviting families affected

Jul 2, 2021 Belizean Students in Taiwan Participate in Virtual Research Conference Belizean students studying in the Republic of China (Taiwan) are preparing to participate in a virtual academic conference this Saturday.  Each participant will get an opportunity to present the research they conducted during their tertiary level studies there.  The event is being hosted by the Belize Ambassador to Taiwan, Doctor Candice Pitts, and will be streamed live on Channel Five. Ambassador Pitt...

uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in June ~ uniQure to host virtual Research & Development Day on June 22, 2021 ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Jefferies Virtual Healthcare Conference, June 1 - 4, 2021 Members of...

~ uniQure to host virtual Research & Development Day on June 22, 2021 ~LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for

April 14, 2021 healthcare Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the extension and expansion of their joint Virtual Research and Development Center (VRDC) to explore new molecules from Boehringer Ingelheim’s KRAS (Kirsten rat sarcoma) and TRAILR2 (TNF-related apoptosis-inducing ligand receptor...

 E-Mail HOUSTON and Ingelheim, Germany ? The University of Texas MD Anderson Cancer Center and Boehringer Ingelheim today announced the extension and expansion of their joint Virtual Research and Development Center (VRDC) to explore new molecules from Boehringer Ingelheims KRAS (Kirsten rat sarcoma) and TRAILR2 (TNF-related apoptosis-inducing ligand receptor 2) portfolios for the potential treatment of lung cancer, particularly non-small cell lung cancer. The collaboration, launched in 2019, ...

(0) Agreement builds on successful preclinical studies in gastrointestinal cancers through the joint Virtual Research and Development Center (VRDC) The continued collaboration will explore lung cancer targeting KRAS and TRAILR2 molecules from Boehringer Ingelheims growing portfolio of cancer treatments and builds on its commitment to delivering first-in-class treatment options to people living with cancer Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announce...